Blue Jet Healthcare shares jump over 4% after firm launches QIP issue with ₹531.70/share floor price

Pharmaceutical company Blue Jet Healthcare shares surged more than 4% after the opening bell on Tuesday, July 7, after the firm launched its qualified institutional placement (QIP) issue in an effort to raise funds from stock market investors, according to an exchange filing.

NSE data showed that Blue Jet Healthcare share price jumped 4.3% to its intraday high of ₹586.30 on Tuesday’s market, compared to ₹561.95 at the previous stock market close. The company approved the opening of the QIP issue on Monday evening.

After the initial market gains, the company’s stock was trading 0.27% higher at ₹563.45 on Tuesday morning market hours, according to the exchange data.

What’s the floor price of Blue Jet Healthcare QIP?

Blue Jet Healthcare’s board of directors on Monday evening fixed the floor price of the QIP issue after a meeting with the company’s Investment and Finance Committee, as per the NSE filing.

The company’s board approved the preliminary placement document while fixing the floor price of the QIP issue at ₹531.70 per equity share based on the pricing formula under the guidelines of the capital markets regulator.

Blue Jet Healthcare’s QIP issue may offer a discount of not more than 5% on the floor price, as approved by the shareholders through a special resolution on June 17, 2026, according to the NSE filing.

Although the issue price will be determined by the book-running lead managers, the issue was authorised to open on July 6, 2026. As part of the QIP issue, the company will issue equity shares with a face value of ₹2 apiece.

Reports suggest the total size of the QIP fundraising is around ₹600 crore, as the firm aims to raise funds from stock market investors.

This comes after, in the Q4 results, Blue Jet Healthcare disclosed that the company has plans to raise around ₹1,000 crore through QIP preferential allotments, subject to the approval of the shareholders.